Continuing Medical Education (CME) Article from Psychiatric Times: Current Treatments for Cannabis Use Disorder
This 1 CME credit article evaluates evidence-based behavioral treatments, medications, and management strategies for cannabis use disorder.
Our sister publication, Psychiatric Times, is currently offering a continuing medical education (CME) article for 1 credit. According to their website, the goal of this activity is to evaluate evidence-based behavioral treatments, medications, and management strategies for cannabis use disorder. This accredited continuing education (CE) activity is intended for psychiatrists, psychologists, primary care physicians, physician assistants, nurse practitioners, and other health care professionals seeking to improve the care of patients with mental health disorders.
Premiere Date: December 20, 2022
Expiration Date: June 20, 2024
Click here to read the CME article from Psychiatric Times: https://www.psychiatrictimes.com/view/current-treatments-for-cannabis-use-disorder
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
